Average Co-Inventor Count = 2.51
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Astellas Institute for Regenerative Medicine (14 from 35 patents)
2. Stem Cell & Regenerative Medicine International, Inc. (2 from 2 patents)
3. Advanced Cell Technology, Inc. (1 from 20 patents)
4. Ocata Therapeutics, Inc. (1 from 10 patents)
18 patents:
1. 12109239 - Methods for production of human hemogenic endothelial cells from pluripotent stem cells and compositions thereof
2. 12076347 - Methods for production of platelets from pluripotent stem cells and compositions thereof
3. 12049642 - Corneal endothelial cells with increased cell density and compositions thereof
4. 11566228 - Hemangio-colony forming cells
5. 11400118 - Methods for production of platelets from pluripotent stem cells and compositions thereof
6. 11241460 - Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
7. 10894065 - Methods for production of platelets from pluripotent stem cells and compositions thereof
8. 10426799 - Methods for production of platelets from pluripotent stem cells and compositions thereof
9. 10307444 - Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
10. 9993503 - Methods for production of platelets from pluripotent stem cells and compositions thereof
11. 9988603 - Large scale generation of functional megakaryocytes and platelets from human embryonic stem cells under stromal-free conditions
12. 9988602 - Methods for producing enucleated erythroid cells derived from pluripotent stem cells
13. 9938500 - Hemangio-colony forming cells
14. 9763984 - Methods for production of platelets from pluripotent stem cells and compositions thereof
15. 9752118 - Method of directed differentiation producing corneal endothelial cells from neural crest stem cells by PDGFB and DKK2, compositions thereof, and uses thereof